Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 7
Submit an article Journal homepage
225
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Mantle cell lymphoma turned SOX11 negative after ibrutinib: a report of two cases

Toshiki TeraoDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba, JapanCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-6728-3346
ORCID Icon,
Kentaro NaritaDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba, Japan
,
Takafumi TsushimaDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba, Japan
,
Daisuke MiuraDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba, Japan
,
Masami TakeuchiDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba, Japan
&
Kosei MatsueDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical Center, Chiba, Japan
Pages 1769-1771 | Received 10 Jan 2020, Accepted 10 Mar 2020, Published online: 23 Apr 2020

References

  • Teras LR, DeSantis CE, Cerhan JR, et al. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;66(6):443–459.
  • Rui L, Schmitz R, Ceribelli M, et al. Malignant pirates of the immune system. Nat Immunol. 2011;12(10):933–940.
  • Maruyama D, Nagai H, Fukuhara N, et al. Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma. Cancer Sci. 2016;107(12):1785–1790.
  • Hoster E, Rosenwald A, Berger F, et al. Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European Mantle Cell Lymphoma Network. JCO. 2016;34(12):1386–1394.
  • Jain P, Wang M. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. Am J Hematol. 2019;94(6):710–725.
  • Martin P, Maddocks K, Leonard JP, et al. Postibrutinib outcomes in patients with mantle cell lymphoma. Blood. 2016;127(12):1559–1563.
  • Rule S, Dreyling M, Goy A, et al. Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysis. Haematologica. 2019;104(5):e211–e214.
  • Ek S, Dictor M, Jerkeman M, et al. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood. 2008;111(2):800–805.
  • Nygren L, Baumgartner Wennerholm S, Klimkowska M, et al. Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood. 2012;119(18):4215–4223.
  • Royo C, Navarro A, Clot G, et al. Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease. Leukemia. 2012;26(8):1895–1898.
  • Seto M. Cyclin D1-negative mantle cell lymphoma. Blood. 2013;121(8):1249–1250.
  • Kuo PY, Jatiani SS, Rahman AH, et al. SOX11 augments BCR signaling to drive MCL-like tumor development. Blood. 2018;131(20):2247–2255.
  • Hu G, Gupta SK, Troska TP, et al. Long non-coding RNA profile in mantle cell lymphoma identifies a functional lncRNA ROR1-AS1 associated with EZH2/PRC2 complex. Oncotarget. 2017;8:80223–80234.
  • Mohanty A, Sandoval N, Phan A, et al. Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma. Blood. 2019;133(4):306–318.
  • Hershkovitz-Rokah O, Pulver D, Lenz G, et al. Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects. Br J Haematol. 2018;181(3):306–319.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.